Anti-Human PD-L1, Human Antibody, MSB 0010718C, MSB0010718C
Avelumab (Anti-Human PD-L1) a fully human IgG1 anti-PD-L1 monoclonal antibody (mAb) with potential antibody-dependent cell-mediated cytotoxicity (ADCC). Avelumab enhances ADCC on several cancer cell lines expressing PD-L1. Avelumab can be used for the study of chordoma[1].
Molecular Weight:
(150 kDa)
Purity:
99.30
CAS Number:
[1537032-82-8]
Target:
PD-1/PD-L1
Application Notes:
Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
